PharmaShots | Incisive News in 3 Shots

Subscribe Now

Tempus

Tempus Reports the US FDA’s Approval of Tempus ECG-AF to Detect Patients at Risk of Atrial Fibrillation

Tempus Reports the US FDA’s Approval of Tempus ECG-AF to Detect Patients at Risk of Atrial Fibrillation

June 27, 2024

Tempus Reports Initiation of an Open-Label P-II Study in Collaboration with GSK to Evaluate Zejula (niraparib) to Treat Advanced or Metastatic Solid Tumors

Tempus Reports Initiation of an Open-Label P-II Study in Collaboration with GSK to Evaluate Zejula (niraparib) to Treat Advanced o...

January 14, 2022

PharmaShots Weekly Snapshots (November 08, 12, 2021)

PharmaShots Weekly Snapshots (November 08, 12, 2021)

November 12, 2021

Kronos Bio Signs a Multi-Year Collaboration with Tempus for Access to its Platform

Kronos Bio Signs a Multi-Year Collaboration with Tempus for Access to its Platform

November 9, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us